(by Veronika Kyrylenko | The New American) – Biotechnology company Moderna Therapeutics has launched a large-scale testing of its COVID jab on infants as young as six months old. The vaccine clinical trial, called KidCOVE, is being carried out at 81 locations across 30 states on some 13,275 healthy children between six months and 12 years old. The first participants were enrolled in the trial in March 2021 (the same time when Moderna’s competitor Pfizer started the same trials in the same cohort). The study is estimated to be completed in June 2023. The primary purpose of the study, according to Moderna, is […]

This post was originally published on this site